Rezultati - Andrew A. Grimm
- Showing 1 - 6 results of 6
-
1
Assessing the therapeutic potential of lab‐made hepatocytes od Milad Rezvani, Andrew A. Grimm, Holger Willenbring
Izdano 2016Revisão -
2
-
3
-
4
Increased dosage of mammalian Sir2 in pancreatic β cells enhances glucose-stimulated insulin secretion in mice od Kathryn A. Moynihan, Andrew A. Grimm, Marie M. Plueger, Ernesto Bernal–Mizrachi, Eric L. Ford, Corentin Cras‐Méneur, M. Alan Permutt, Shin‐ichiro Imai
Izdano 2005Artigo -
5
Safety and Efficacy of Teduglutide in Pediatric Patients With Intestinal Failure due to Short Bowel Syndrome: A 24‐Week, Phase III Study od Samuel A. Kocoshis, Russell J. Merritt, Susan Hill, Susan Protheroe, Beth A. Carter, Simon Horslen, Simin Hu, Stuart S. Kaufman, David F. Mercer, Mikko P. Pakarinen, Robert S. Venick, Paul W. Wales, Andrew A. Grimm
Izdano 2019Artigo -
6
In Vivo Hepatic Reprogramming of Myofibroblasts with AAV Vectors as a Therapeutic Strategy for Liver Fibrosis od Milad Rezvani, Regina Español‐Suñer, Yann Malato, Laure Dumont, Andrew A. Grimm, Eike Kienle, Jay G. Bindman, Ellen Wiedtke, Bernadette Y. Hsu, Syed Naqvi, Robert F. Schwabe, Carlos U. Corvera, Dirk Grimm, Holger Willenbring
Izdano 2016Artigo
Iskalna orodja:
Sorodne teme
Medicine
Biology
Internal medicine
Biochemistry
Cell biology
Cancer research
Gene
Stem cell
Adverse effect
Beta cell
Bioartificial liver device
Biosynthesis
Biotechnology
Business
Carbohydrate metabolism
Cell
Cell therapy
Chemistry
Clinical endpoint
Disease
Endocrinology
Enteral administration
Enzyme
Fibrosis
Gastroenterology
Genetically modified mouse
Genetics
Glycogen storage disease
Hepatic fibrosis
Hepatocyte